Skip to search.
 BSE Down 1.12% NSE Down 1.05%

Isis Pharmaceuticals, Inc. (ISIS)

-NasdaqGS
67.76 Up 0.59(0.88%) 23 May 1:30AM
Add to Portfolio
Prev Close:67.17
Open:66.84
Bid:N/A
Ask:68.01 x 4000
1y Target Est:68.11
Beta:1.24
Earnings Date:3 Aug - 7 Aug (Est.)
Day's Range:66.50 - 68.09
52wk Range:25.82 - 77.80
Volume:1,284,341
Avg Vol (3m):2,656,480
Market Cap:8.11B
P/E (ttm):N/A
EPS (ttm):-0.21
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for ISIS at this time.

Comparison

Symbol% ChgMkt Cap
ISISUp 0.88%8.11B
ENZDown 3.76%116.16M
GILDUp 0.44%165.00B
SRPTUp 8.08%1.09B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):32.35
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.32
Quarterly EPS Est (Jun-15) :0.34
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):-9.11

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Isis Pharmaceuticals, Inc. engages in the discovery and development of antisense drugs using novel drug discovery platform. The company’s flagship product includes the KYNAMRO injection, which is an apo-B synthesis inhibitor for patients with... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback